News FDA approves Incyte's Pemazyre for rare bile duct cancer The FDA has approved Incyte's Pemazyre (pemigatinib), the first targeted treatment for a rare cancer of the bile duct.
News NVIDIA sinks $2bn into AI cloud provider Nebius NVIDIA has agreed a $2 billion partnership with AI cloud provider Nebius to ramp up infrastructure as demand soars in the life sciences.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
